Caramifen (edisilaat)
Gecertificeerd

Caramifen (edisilaat)

Catalog #: HY-B1585B
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Caramiphen edisylate (Parpanil edisylate) is an anticholinergic agent with NMDA receptor antagonist activity. Caramiphen edisylate can be used to inhibit diseases related to cholinergic neurotransmission. Caramiphen edisylate exerts its pharmacological effects by blocking cholinergic effects[1].

CAS Number

125-86-0

Product Name Alternative

Parpanil (edisylate)

UNSPSC

12352005

Hazard Statement

H302

Target

IGluR

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Smiles

O=C(C1(CCCC1)C2=CC=CC=C2)OCCN(CC)CC.O=S(O)(CCS(=O)(O)=O)=O.[1/2]

Molecular Formula

C18H27NO2·1/2C2H6O6S2

Molecular Weight

384.39

Precautions

P264-P270-P330-P501

References & Citations

[1]Figueiredo TH, et al. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure. Exp Biol Med (Maywood) . 2023 Apr;248 (7) :612-623.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-B1585B/

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

NMDA Receptor

Beschrijving

Caramiphen edisylate (Parpanil edisylate) is an anticholinergic agent with NMDA receptor antagonist activity. Caramiphen edisylate can be used to inhibit diseas

Specificaties

ProductnaamCaramifen (edisilaat)
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-B1585B